Insider · CIK 0001960048
Elvia Cowan
officer
Files at PCVX (Vaxcyte, Inc.). First filing Oct 7, 2026, latest Oct 7, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1.6M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PCVX: Vaxcyte, Inc.
PCVXOct 9, 2026 · close 71.38
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Vaxcyte, Inc. | $1.6M 19,000 shares | -41% | +83% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock10b5-1 | +19,000 | $25.92 | $492k | 46,860 | 5 d ago |
| Oct 5, 2026 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -19,000 | $86.74 | $1.6M | 27,860 | 5 d ago |
| Oct 5, 2026 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -19,000 | $0.00 | $0 | 74,068 | 5 d ago |
| Sep 8, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,327 | $60.36 | $80k | 27,860 | 33 d ago |
| Aug 31, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -243 | $60.74 | $15k | 29,513 | 40 d ago |
| Sep 2, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -326 | $61.58 | $20k | 29,187 | 40 d ago |
| Feb 27, 2025 | PCVX Vaxcyte, Inc. | AGrant or award Common Stock | +5,379 | $0.00 | $0 | 24,673 | Mar 3, 2025 |
| Feb 28, 2025 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -242 | $73.02 | $18k | 24,431 | Mar 3, 2025 |
| Mar 3, 2025 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -325 | $72.10 | $23k | 24,106 | Mar 3, 2025 |
| Feb 27, 2025 | PCVX Vaxcyte, Inc. | AGrant or award Stock Option (right to buy)derivative | +17,961 | $0.00 | $0 | 17,961 | Mar 3, 2025 |
| Dec 16, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock | +7,716 | $25.92 | $200k | 19,294 | Dec 18, 2024 |
| Dec 16, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative | -7,716 | $0.00 | $0 | 106,284 | Dec 18, 2024 |
| Nov 7, 2024 | PCVX Vaxcyte, Inc. | AGrant or award Performance Stock Option (right to buy)derivative | +11,900 | $0.00 | $0 | 11,900 | Nov 8, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.